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We investigated the serum macrophage migration
inhibitory factor (MIF) levels of palmoplantar pustu-
losis patients, before and after the tonsillar provoca-
tion test. Higher serum MIF levels of palmoplantar
pustulosis patients were decreased after the tonsillar
provocation test (n /29). To confirm these phenom-
ena, two patients with acute tonsillitis had their
changes in body temperature, C-reactive protein
(CRP) and serum MIF levels examined during the
course of their illness. Surprisingly, increased MIF
preceded fever and CRP elevation, and MIF subse-
quently decreased at the onset of fever and CRP
elevation. Since MIF is an initiator of other proin-
flammatory cytokines, we suggest that the induction
of MIF may precede other inflammatory conditions.
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Macrophage migration inhibitory factor (MIF) is an
important cytokine in the innate immune system and
plays an important role in the control of such
inflammatory responses.
1 Once released, MIF in-
duces the expression of proinflammatory mediators
by macrophages and activates T cells, thereby
promoting inflammatory and immune responses.
2
Elevated concentrations of MIF have been detected
in sera from patients with a variety of inflammatory
disorders such as atopic dermatitis.
3
We investigated serum levels of MIF in patients
with palmoplantar pustulosis (PPP) and compared
them before and after the tonsillar provocation test
(TPT) in each patient. PPP is a common chronic skin
disease characterized by recurrent sterile pustules
and usually also by erythematous, scaly skin on the
palms and soles. It has been reported that PPP is
closely related to focal tonsil infections, and that
tonsillectomy is often effective in curing this condi-
tion.
4 The TPT is a well-established laboratory
procedure to evaluate whether the tonsils participate
in the etiology of inflammatory skin diseases such as
PPP and psoriasis.
4 Twenty-nine patients with PPP
(10 males and 19 females; aged 19/78 years, mean
age 46.39 /1.3 years) and 135 healthy volunteers (47
males and 88 females; aged 22/73 years, mean age
47.69 /0.82 years) were enrolled in the present study.
None of the patients had been treated with systemic
immunosuppressants before the TPT. Controls did
not have any acute or chronic illness at the time of
the study. All participants gave informed consent.
The TPT was performed by indirect ultramicrowave
irradiation (Micro thermy ME-320; OG Giken,
Okayama, Japan) as described previously.
4 Blood
samples were collected before and 1 h after TPT.
Serum MIF was measured by enzyme-linked immu-
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293nosorbent assay (ELISA) as previously described.
3
Briefly, the anti-human MIF antibody dissolved in 50
ml of phosphate-buffered saline was added to each
well of a 96-well microtiter plate. After incubation for
1 h at room temperature, the plate was washed and
50 ml of biotin-conjugated anti-human MIF antibody
was added. Following incubation, the plate was again
washed. Then avidin-conjugated horseradish perox-
idase was added to individual wells, which were
further incubated for 1 h at room temperature. After
washing again, 50 ml of substrate solution containing
200 mgo fo-phenylenediamine and 10 ml of 30%
hydrogen peroxide in 10 ml of citrate-phosphate
buffer (pH 5.0) were added. Then the reaction was
terminated with 50 ml of 1 N sulfuric acid. The
absorbance at 492 nm was measured with an ELISA
plate reader (Model 3550; Bio-Rad, Tokyo, Japan).
For this assay we used recombinant human MIF to
obtain the standard curve, in which good linearity
was demonstrated between MIF concentrations (1/
200 ng/ml) and absorbency. C-reactive protein (CRP)
was measured using a Hitachi modular system 7350
(normal range, 0/0.39 mg/dl).
Table 1 summarizes the data. The mean serum MIF
level before the TPT in the PPP patients was 11.329 /
2.0 ng/ml (n /29), which was significantly higher
than that of control subjects (4.789 /0.32 ng/ml,
n /135; p /0.0027). In contrast, the mean serum
MIF level in the PPP patients was significantly
decreased after the TPT (8.39 /1.1 ng/ml)(before
TPT versus after TPT, p /0.016). Elevation of CRP
was detected after the TPT in each patient (data not
shown).
To confirm these phenomena, two patients with
acute tonsillitis had their changes in body tempera-
ture, CRP and serum MIF levels examined during the
course of their illness. Six-year-old and 9-year-old
male patients were admitted to Hokkaido University
hospital with acute tonsillitis. In both cases, increased
serum MIF levels preceded both fever and CRP
elevation, MIF levels were also reduced at the onset
of fever and elevation of CRP (Fig. 1).
In vitro cytokine measurements of tonsil mono-
nuclear cells stimulated with a-streptococcal antigens
revealed significant tumor necrosis factor alpha (TNF-
a) production in the culture supernatants from PPP
patients but not controls.
4 These findings suggested a
close immunologic link between the tonsillitis and
proinflammatory cytokines. It has been shown that
the TPT induces an increased level of some inflam-
matory cytokines such as TNF-a, interleukin-1 and
interleukin-6 in peripheral blood monocytes of
patients with certain focal infectious skin diseases.
We have observed two cases with acute tonsillitis,
which showed a transient increase in serum MIF
preceding an elevation of CRP and fever. In addition,
MIF levels were decreased at the onset of fever and
the elevation of CRP. Furthermore, significantly
higher MIF contents were observed in the sera of
patients with PPP than in normal subjects. Unexpect-
edly, the MIF serum level fell after the TPT. The fact
that the serum MIF level significantly decreased at the
onset of fever and elevation of CRP after the TPT
seems to be a surprising, but interesting, result.
Monocytes and macrophages are the main sources
of MIF, which is released after exposure to bacterial
endotoxins and exotoxins such as lipopolysaccharide
and streptococcal pyrogenic exotoxin A.
2 Thus, these
effects may be mediated by a number of proinflam-
Table 1. Serum MIF contents of PPP patients and MIF
contents fell after the TPT
Patients Number of
patients
Serum MIF
(ng/ml)
a
Control 135 4.789 /0.32
PPP patients before the TPT 29 11.329 /2.0*
PPP patients after the TPT 29 8.39 /1.1**
aThe Mann/Whitney U-test was used for analysis of the variance in
serum MIF levels contents between several of the two groups.
*Control versus patients before the TPT, p /0.0027, **PPP patients
before the TPT versus after the TPT, p /0.016.
FIG. 1. Changes in body temperature, serum MIF, and CRP in patients with acute tonsillitis. The patients with acute tonsillitis
(case 1, a 6-year-old male; and case 2, a 9-year-old male) were admitted to Hokkaido University hospital. Body temperature,
CRP (I), and serum MIF (j) were examined during the course of admission.
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2 Since
MIF is an initiator of other proinflammatory cytokines
such as TNF-a and IL-1, and regulates the induction
of those cytokines,
1,5 our findings suggest that the
induction of MIF may precede that of other inflam-
matory conditions.
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